Scarica l'app Stockscreener
27.78
0.47%
0.13
Dopo l'orario di chiusura:
27.78
Precedente Chiudi:
$27.65
Aprire:
$27.56
Volume 24 ore:
240.60K
Relative Volume:
0.65
Capitalizzazione di mercato:
$863.38M
Reddito:
$566.77M
Utile/perdita netta:
$48.16M
Rapporto P/E:
23.34
EPS:
1.19
Flusso di cassa netto:
$274.29M
1 W Prestazione:
+3.39%
1M Prestazione:
-1.28%
6M Prestazione:
-16.88%
1 anno Prestazione:
-25.94%
Intervallo 1D:
$27.52
$28.19
Intervallo di 1 settimana:
$26.16
$28.19
Portata 52W:
$23.23
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Confronta COLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
27.78 | 863.38M | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
158.06 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.38 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.63 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.39 | 18.55B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.70 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
BlackRock, Inc. Reduces Stake in Collegium Pharmaceutical Inc. - GuruFocus
Wells Fargo & Company MN Sells 9,987 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Collegium Pharmaceutical (COLL) Projected to Post Earnings on Thursday - Defense World
Raymond James Financial Inc. Invests $2.43 Million in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Price Target at $43.60 - Defense World
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewswire
Collegium Pharmaceutical Q1 2025 Earnings Date Revealed: Key Financial Results Coming May 8 - Stock Titan
JPMorgan Chase & Co. Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Russell Investments Group Ltd. Trims Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? - Yahoo Finance
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Federated Hermes Inc. - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to “Buy” at StockNews.com - Defense World
Geode Capital Management LLC Sells 5,098 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Alliancebernstein L.P. Sells 66,120 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by LPL Financial LLC - Defense World
Trading (COLL) With Integrated Risk Controls - news.stocktradersdaily.com
Collegium Appoints Nancy S. Lurker to its Board of Directors - The Globe and Mail
2 Reasons to Watch COLL and 1 to Stay Cautious - Yahoo Finance
2 Reasons To Watch COLL And 1 To Stay Cautious - Barchart.com
Wellington Management Group LLP Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
StockNews.com Upgrades Collegium Pharmaceutical (NASDAQ:COLL) to “Strong-Buy” - Defense World
Vanguard Group Inc. Sells 63,876 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Earns “Buy” Rating from Needham & Company LLC - Defense World
Sei Investments Co. Has $294,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
What Analysts Are Saying About Collegium Pharmaceutical Stock - Benzinga
Corebridge Financial Inc. Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Position Cut by American Century Companies Inc. - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 52-Week Low – Time to Sell? - Defense World
Prudential Financial Inc. Trims Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Has Caught The Eye Of Investors - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Thrivent Financial for Lutherans - Defense World
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average? - Yahoo Finance
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack - Yahoo Finance
Teacher Retirement System of Texas Has $274,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Exclusive: Collegium Leaders Set for Key Investor Presentation at Needham Conference - Stock Titan
Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.60 - Defense World
HighTower Advisors LLC Has $428,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Raymond James Financial Inc. Makes New Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Swiss National Bank Has $1.81 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
HC Wainwright Has Optimistic Outlook of COLL Q3 Earnings - Defense World
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting - GlobeNewswire
Q1 EPS Estimate for Collegium Pharmaceutical Cut by Analyst - Defense World
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - Yahoo Finance
Collegium Pharmaceutical (NASDAQ:COLL) Receives “Buy” Rating from HC Wainwright - Defense World
Collegium pharmaceutical CFO Colleen Tupper sells shares for $228,250 By Investing.com - Investing.com South Africa
Collegium Pharmaceutical EVP sells shares worth $624,794 - Investing.com India
Collegium Pharmaceutical EVP sells shares worth $624,794 By Investing.com - Investing.com Australia
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.03%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):